Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure

M.C. Jaye; J.A. Krawiec; N. Campobasso; A. Smallwood; C.Y. Qiu; Q. Lu; J.J. Kerrigan; M.D.L. Alvaro; B. Laffitte; W.S. Liu; J.P. Marino; C.R. Meyer; J.A. Nichols; D.J. Parks; P. Perez; L. Sarov-Blat; S.D. Seepersaud; K.M. Steplewski; S.K. Thompson; P. Wang; M.A. Watson; C.L. Webb; David Haigh; J.A. Caravella; C.H. Macphee; T.M. Willson; J.L. Collins

doi:10.1021/jm050532w

Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure

M.C. Jaye, J.A. Krawiec, N. Campobasso, A. Smallwood, C.Y. Qiu, Q. Lu, J.J. Kerrigan, M.D.L. Alvaro, B. Laffitte, W.S. Liu, J.P. Marino, C.R. Meyer, J.A. Nichols, D.J. Parks, P. Perez, L. Sarov-Blat, S.D. Seepersaud, K.M. Steplewski, S.K. Thompson, P. WangM.A. Watson, C.L. Webb, David Haigh, J.A. Caravella, C.H. Macphee, T.M. Willson, J.L. Collins

Research output: Contribution to journal › Article › peer-review

32 Citations (Scopus)

Abstract

Substituted 3-(phenylamino)-1H-pyrrole-2,5-diones were identified from a high throughput screen as inducers of human ATP binding cassette transporter A1 expression. Mechanism of action studies led to the identification of GSK3987 (4) as an LXR ligand. 4 recruits the steroid receptor coactivator-1 to human LXR alpha and LXRP with EC(50)s of 40 nM, profiles as an LXR agonist in functional assays, and activates LXR though a mechanism that is similar to first generation LXR agonists.

Original language	English
Pages (from-to)	5419-5422
Number of pages	4
Journal	Journal of Medicinal Chemistry
Volume	48
Issue number	17
DOIs	https://doi.org/10.1021/jm050532w
Publication status	Published - 25 Aug 2005

ASJC Scopus subject areas

Organic Chemistry

Access to Document

10.1021/jm050532w

Cite this

Jaye, M. C., Krawiec, J. A., Campobasso, N., Smallwood, A., Qiu, C. Y., Lu, Q., Kerrigan, J. J., Alvaro, M. D. L., Laffitte, B., Liu, W. S., Marino, J. P., Meyer, C. R., Nichols, J. A., Parks, D. J., Perez, P., Sarov-Blat, L., Seepersaud, S. D., Steplewski, K. M., Thompson, S. K., ... Collins, J. L. (2005). Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure. Journal of Medicinal Chemistry, 48(17), 5419-5422. https://doi.org/10.1021/jm050532w

Jaye, M.C. ; Krawiec, J.A. ; Campobasso, N. ; Smallwood, A. ; Qiu, C.Y. ; Lu, Q. ; Kerrigan, J.J. ; Alvaro, M.D.L. ; Laffitte, B. ; Liu, W.S. ; Marino, J.P. ; Meyer, C.R. ; Nichols, J.A. ; Parks, D.J. ; Perez, P. ; Sarov-Blat, L. ; Seepersaud, S.D. ; Steplewski, K.M. ; Thompson, S.K. ; Wang, P. ; Watson, M.A. ; Webb, C.L. ; Haigh, David ; Caravella, J.A. ; Macphee, C.H. ; Willson, T.M. ; Collins, J.L. / Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure. In: Journal of Medicinal Chemistry. 2005 ; Vol. 48, No. 17. pp. 5419-5422.

@article{caeeb05476e04f39959acd17b1abbfe9,

title = "Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure",

abstract = "Substituted 3-(phenylamino)-1H-pyrrole-2,5-diones were identified from a high throughput screen as inducers of human ATP binding cassette transporter A1 expression. Mechanism of action studies led to the identification of GSK3987 (4) as an LXR ligand. 4 recruits the steroid receptor coactivator-1 to human LXR alpha and LXRP with EC(50)s of 40 nM, profiles as an LXR agonist in functional assays, and activates LXR though a mechanism that is similar to first generation LXR agonists.",

author = "M.C. Jaye and J.A. Krawiec and N. Campobasso and A. Smallwood and C.Y. Qiu and Q. Lu and J.J. Kerrigan and M.D.L. Alvaro and B. Laffitte and W.S. Liu and J.P. Marino and C.R. Meyer and J.A. Nichols and D.J. Parks and P. Perez and L. Sarov-Blat and S.D. Seepersaud and K.M. Steplewski and S.K. Thompson and P. Wang and M.A. Watson and C.L. Webb and David Haigh and J.A. Caravella and C.H. Macphee and T.M. Willson and J.L. Collins",

year = "2005",

month = aug,

day = "25",

doi = "10.1021/jm050532w",

language = "English",

volume = "48",

pages = "5419--5422",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "17",

}

Jaye, MC, Krawiec, JA, Campobasso, N, Smallwood, A, Qiu, CY, Lu, Q, Kerrigan, JJ, Alvaro, MDL, Laffitte, B, Liu, WS, Marino, JP, Meyer, CR, Nichols, JA, Parks, DJ, Perez, P, Sarov-Blat, L, Seepersaud, SD, Steplewski, KM, Thompson, SK, Wang, P, Watson, MA, Webb, CL, Haigh, D, Caravella, JA, Macphee, CH, Willson, TM & Collins, JL 2005, 'Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure', Journal of Medicinal Chemistry, vol. 48, no. 17, pp. 5419-5422. https://doi.org/10.1021/jm050532w

Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure. / Jaye, M.C.; Krawiec, J.A.; Campobasso, N.; Smallwood, A.; Qiu, C.Y.; Lu, Q.; Kerrigan, J.J.; Alvaro, M.D.L.; Laffitte, B.; Liu, W.S.; Marino, J.P.; Meyer, C.R.; Nichols, J.A.; Parks, D.J.; Perez, P.; Sarov-Blat, L.; Seepersaud, S.D.; Steplewski, K.M.; Thompson, S.K.; Wang, P.; Watson, M.A.; Webb, C.L.; Haigh, David; Caravella, J.A.; Macphee, C.H.; Willson, T.M.; Collins, J.L.

In: Journal of Medicinal Chemistry, Vol. 48, No. 17, 25.08.2005, p. 5419-5422.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure

AU - Jaye, M.C.

AU - Krawiec, J.A.

AU - Campobasso, N.

AU - Smallwood, A.

AU - Qiu, C.Y.

AU - Lu, Q.

AU - Kerrigan, J.J.

AU - Alvaro, M.D.L.

AU - Laffitte, B.

AU - Liu, W.S.

AU - Marino, J.P.

AU - Meyer, C.R.

AU - Nichols, J.A.

AU - Parks, D.J.

AU - Perez, P.

AU - Sarov-Blat, L.

AU - Seepersaud, S.D.

AU - Steplewski, K.M.

AU - Thompson, S.K.

AU - Wang, P.

AU - Watson, M.A.

AU - Webb, C.L.

AU - Haigh, David

AU - Caravella, J.A.

AU - Macphee, C.H.

AU - Willson, T.M.

AU - Collins, J.L.

PY - 2005/8/25

Y1 - 2005/8/25

N2 - Substituted 3-(phenylamino)-1H-pyrrole-2,5-diones were identified from a high throughput screen as inducers of human ATP binding cassette transporter A1 expression. Mechanism of action studies led to the identification of GSK3987 (4) as an LXR ligand. 4 recruits the steroid receptor coactivator-1 to human LXR alpha and LXRP with EC(50)s of 40 nM, profiles as an LXR agonist in functional assays, and activates LXR though a mechanism that is similar to first generation LXR agonists.

AB - Substituted 3-(phenylamino)-1H-pyrrole-2,5-diones were identified from a high throughput screen as inducers of human ATP binding cassette transporter A1 expression. Mechanism of action studies led to the identification of GSK3987 (4) as an LXR ligand. 4 recruits the steroid receptor coactivator-1 to human LXR alpha and LXRP with EC(50)s of 40 nM, profiles as an LXR agonist in functional assays, and activates LXR though a mechanism that is similar to first generation LXR agonists.

UR - http://www.scopus.com/inward/record.url?scp=23944439351&partnerID=8YFLogxK

U2 - 10.1021/jm050532w

DO - 10.1021/jm050532w

M3 - Article

VL - 48

SP - 5419

EP - 5422

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 17

ER -

Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this